Legal
Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide, seeking potentially āhundreds of millionsā in damages, John Kuckelman, the pharmaās general counsel, said. The wellness platform pulled its version of the drug just days after launching it.
Novo Nordisk has also spoken out strongly against Hims & Hersā compounded Wegovy pill, with CEO Maziar Mike Doustdar telling investors the knockoff version is a waste of money.
Nader Pourhassan, who led CytoDyn for nearly 10 years, was convicted in December 2024 of misleading investors regarding the biotechās investigational COVID-19 and HIV drug, which artificially inflated its share price.
Reporting Q4 and full year earnings on Wednesday, J&J executives hailed growth across the healthcare giantās portfolio while standing fast on its talc lawsuit and tariffs.
Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with information related to the companyās manufacturing operations that had yet to be made public.
Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers in exclusive partnerships, disallowing them from offering compounded versions of GLP-1 medicines.
The agreement, which BMO Capital Markets called a āmild positiveā for Structure, appears to address Rocheās concerns about the composition of investigational weight loss drug CT-996.
The banker allegedly shared details of a series of multibillion-dollar buyouts by companies including AbbVie, GSK and Pfizer.
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassmanās Michael Pietrack speaks to employment attorney Howard Matalon, JD, partner at OlenderFeldman, on how to evaluate the fine print of an employment agreement.
After GSK subsidiary Tesaro filed a lawsuit Thursday claiming that AnaptysBio breached ācertain requirementsā under their 2014 license agreement involving GSKās Jemperli, Anaptys responded Friday morning.
PRESS RELEASES